These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9819812)

  • 21. Preclinical immunogenicity testing using anti-drug antibody analysis of GX-G3, Fc-fused recombinant human granulocyte colony-stimulating factor, in rat and monkey models.
    Kim YJ; Koh EM; Song CH; Byun MS; Choi YR; Jeon EJ; Hwang K; Kim SK; Yang SI; Jung KJ
    Sci Rep; 2021 Jun; 11(1):12004. PubMed ID: 34099775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant anti-human HER2/neu IgG3-(GM-CSF) fusion protein retains antigen specificity and cytokine function and demonstrates antitumor activity.
    Dela Cruz JS; Trinh KR; Morrison SL; Penichet ML
    J Immunol; 2000 Nov; 165(9):5112-21. PubMed ID: 11046042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of immune responses to human erythropoietin in cynomolgus monkeys (Macaca fascicularis).
    Ageyama N; Hanazono Y; Shibata H; Ono F; Nagashima T; Ueda Y; Yoshikawa Y; Hasegawa M; Ozawa K; Terao K
    J Vet Med Sci; 2006 May; 68(5):507-10. PubMed ID: 16757897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The induction of prolonged myelopoietic effects in monkeys by GW003, a recombinant human granulocyte colony-stimulating factor genetically fused to recombinant human albumin.
    Xu X; Yang J; Liu Y; Shan C; Wang Q; Chen Z; Cheng Y
    J Pharm Sci; 2015 Feb; 104(2):760-7. PubMed ID: 25174614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mouse/human chimeric anti-HIV-1 gp120 antibody to the principal neutralizing determinant: tolerability and pharmacokinetics in cynomolgus monkeys, Macaca fascicularis.
    Liou RS; Fung MS; Zühlke U; Gudat F; McKinney S; Gordon W; Bee W; Botta L; Gygax D; Chang TW
    Biotherapy; 1992; 5(4):291-9. PubMed ID: 1283953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequential administration of recombinant human granulocyte-macrophage colony-stimulating factor and human erythropoietin for treatment of myelodysplastic syndromes.
    Runde V; Aul C; Ebert A; Grabenhorst U; Schneider W
    Eur J Haematol; 1995 Jan; 54(1):39-45. PubMed ID: 7859874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Granulocyte-macrophage colony-stimulating factor and erythropoietin act competitively to induce two different programs of differentiation in the human pluripotent cell line UT-7.
    Hermine O; Mayeux P; Titeux M; Mitjavila MT; Casadevall N; Guichard J; Komatsu N; Suda T; Miura Y; Vainchenker W
    Blood; 1992 Dec; 80(12):3060-9. PubMed ID: 1467515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Very low doses of GM-CSF administered alone or with erythropoietin in aplastic anemia.
    Kurzrock R; Talpaz M; Gutterman JU
    Am J Med; 1992 Jul; 93(1):41-8. PubMed ID: 1626572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination therapy with recombinant human erythropoietin, interferon-alpha-2b and granulocyte-macrophage colony-stimulating factor in idiopathic myelofibrosis.
    Bourantas KL; Tsiara S; Christou L; Repousis P; Konstantinidou P; Bai M; Seferiadis K
    Acta Haematol; 1996; 96(2):79-82. PubMed ID: 8701705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD45 cell surface antigens are linked to stimulation of early human myeloid progenitor cells by interleukin 3 (IL-3), granulocyte/macrophage colony-stimulating factor (GM-CSF), a GM-CSF/IL-3 fusion protein, and mast cell growth factor (a c-kit ligand).
    Broxmeyer HE; Lu L; Hangoc G; Cooper S; Hendrie PC; Ledbetter JA; Xiao M; Williams DE; Shen FW
    J Exp Med; 1991 Aug; 174(2):447-58. PubMed ID: 1713254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A low-affinity human granulocyte-macrophage colony-stimulating factor/murine erythropoietin hybrid receptor functions in murine cell lines.
    Jubinsky PT; Nathan DG; Wilson DJ; Sieff CA
    Blood; 1993 Feb; 81(3):587-91. PubMed ID: 8427955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A DNA vaccine encoding the 42 kDa C-terminus of merozoite surface protein 1 of Plasmodium falciparum induces antibody, interferon-gamma and cytotoxic T cell responses in rhesus monkeys: immuno-stimulatory effects of granulocyte macrophage-colony stimulating factor.
    Kumar S; Villinger F; Oakley M; Aguiar JC; Jones TR; Hedstrom RC; Gowda K; Chute J; Stowers A; Kaslow DC; Thomas EK; Tine J; Klinman D; Hoffman SL; Weiss WW
    Immunol Lett; 2002 Apr; 81(1):13-24. PubMed ID: 11841841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purification and characterization of two recombinant human granulocyte colony-stimulating factor glycoforms. Pharmacokinetic and activity studies of single-dose administration in mice.
    Rotondaro L; De Paolis E; Ferrero D; D'Alatri L; Raucci G; Fabbri A; Gerwig GJ; Kamerling JP; Mariani MF; Mele A; De Santis R
    Mol Biotechnol; 1999 Apr; 11(2):117-28. PubMed ID: 10464766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The efficacy of single-dose administration of thrombopoietin with coadministration of either granulocyte/macrophage or granulocyte colony-stimulating factor in myelosuppressed rhesus monkeys.
    Neelis KJ; Hartong SC; Egeland T; Thomas GR; Eaton DL; Wagemaker G
    Blood; 1997 Oct; 90(7):2565-73. PubMed ID: 9326222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expansion of granulocyte colony-stimulating factor/chemotherapy-mobilized CD34+ hematopoietic progenitors: role of granulocyte-macrophage colony-stimulating factor/erythropoietin hybrid protein (MEN11303) and interleukin-15.
    Pierelli L; Scambia G; Bonanno G; Coscarella A; De Santis R; Mele A; Battaglia A; Fattorossi A; Romeo V; Menichella G; Mancuso S; Leone G
    Exp Hematol; 1999 Mar; 27(3):416-24. PubMed ID: 10089903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erythropoiesis equivalence, pharmacokinetics and immune response following repeat hematide administration in cynomolgus monkeys.
    Woodburn KW; Schatz PJ; Fong KL; Beaumier P
    Int J Immunopathol Pharmacol; 2010; 23(1):121-9. PubMed ID: 20378000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In polycythemia vera human interleukin 3 and granulocyte-macrophage colony-stimulating factor enhance erythroid colony growth in the absence of erythropoietin.
    de Wolf JT; Beentjes JA; Esselink MT; Smit JW; Halie RM; Clark SC; Vellenga E
    Exp Hematol; 1989 Oct; 17(9):981-3. PubMed ID: 2673832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and haematological parameters of recombinant human erythropoietin after subcutaneous administrations in horses.
    Souillard A; Audran M; Bressolle F; Jaussaud P; Gareau R
    Biopharm Drug Dispos; 1996 Dec; 17(9):805-15. PubMed ID: 8968532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase I study of chimeric human/murine anti-ganglioside G(D2) monoclonal antibody (ch14.18) with granulocyte-macrophage colony-stimulating factor in children with neuroblastoma immediately after hematopoietic stem-cell transplantation: a Children's Cancer Group Study.
    Ozkaynak MF; Sondel PM; Krailo MD; Gan J; Javorsky B; Reisfeld RA; Matthay KK; Reaman GH; Seeger RC
    J Clin Oncol; 2000 Dec; 18(24):4077-85. PubMed ID: 11118469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of endogenous cytokine concentrations after high-dose chemotherapy with autologous bone marrow support.
    Rabinowitz J; Petros WP; Stuart AR; Peters WP
    Blood; 1993 May; 81(9):2452-9. PubMed ID: 7683220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.